Norman D. Schwartz - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-10-30
4:36 pm
Purchase
2025-09-2513DBio-Rad Laboratories, Inc.
BIO
Norman D. Schwartz4,929,036
97.200%
1,700,114increase
(+52.65%)
Filing
History
2025-10-30
4:35 pm
Sale
2025-09-2513DBio-Rad Laboratories, Inc.
BIO
Norman D. Schwartz3,228,922
14.600%
-1,700,114decrease
(-34.49%)
Filing
History
2025-10-28
4:30 pm
Purchase
2025-09-2513DBio-Rad Laboratories, Inc.
BIO
Norman D. Schwartz4,929,036
97.200%
1,700,114increase
(+52.65%)
Filing
History
2025-10-28
4:30 pm
Purchase
2025-09-2513DBio-Rad Laboratories, Inc.
BIO
Norman D. Schwartz3,228,922
14.600%
3,228,922increase
(New Position)
Filing
History